| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/2001 | WO2001001978A1 Medicinal compositions for preventing or treating viral myocarditis |
| 01/11/2001 | WO2001001971A1 Use of cortisol antagonists in the treatment for heat failure |
| 01/11/2001 | WO2001001970A2 New uses potassium channel openers, such as the treatment of epilepsy |
| 01/11/2001 | WO2001001959A1 Ophthalmic compositions in form of aqueous gels |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000061189A3 Water-soluble compositions of bioactive lipophilic compounds |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/11/2001 | WO2000053596A3 Imidazole compounds as histamine h3 ligands |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000043398A3 Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | DE19916108C1 Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung With sugar residues substituted 1,4-benzothiazepine-1,1-dioxide derivatives, processes for their preparation and their use |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2380866A1 Selective npy (y5) antagonists |
| 01/11/2001 | CA2378951A1 Secreted protein zacrp4 |
| 01/11/2001 | CA2378606A1 Agent for occluding blood vessels |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | CA2377795A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | CA2377734A1 Heparin compositions that inhibit clot associated coagulation factors |
| 01/11/2001 | CA2377381A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2375751A1 Use of cortisol antagonists in the treatment for heat failure |
| 01/11/2001 | CA2373883A1 Method of reducing neuronal injury or apoptosis |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | CA2373881A1 Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications |
| 01/10/2001 | EP1067190A1 Gene therapy for enhancing and/or inducing angiogenesis |
| 01/10/2001 | EP1066323A1 Treatment and prevention of vascular disease |
| 01/10/2001 | EP1066311A1 Compositions and methods for the identification of lung tumor cells |
| 01/10/2001 | EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR |
| 01/10/2001 | EP1066286A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 01/10/2001 | EP1066268A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 01/10/2001 | EP1066061A1 Use of scatter factor to enhance angiogenesis |
| 01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
| 01/10/2001 | EP1066039A1 Substituted quinazolines and analogs and the use thereof |
| 01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 01/10/2001 | EP1065931A1 Compositions containing a combination of a creatine compound and a second agent |
| 01/10/2001 | CN1279691A Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279680A Imidazole derivatives with inhabiting activity to transterasa and preparing method thereof |
| 01/10/2001 | CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 01/10/2001 | CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders |
| 01/10/2001 | CN1279666A NPY antagonists |
| 01/10/2001 | CN1279617A Combination of an aldose reductase inhibitor and a glycogen phosphorglase inhibitor |
| 01/10/2001 | CN1279615A Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 01/10/2001 | CN1279606A Use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 01/10/2001 | CN1279605A Inihibition of lipoprotein oxidation |
| 01/10/2001 | CN1279083A Mongolian medicine for curing ischemic heart disease |
| 01/10/2001 | CN1279080A Gingko tea and preparing process thereof |
| 01/10/2001 | CN1279073A Antisenility Chinese medicine |
| 01/10/2001 | CN1279072A Medicine for preventing and curing cardiovascular and cerebrovascular diseases |
| 01/10/2001 | CN1279066A Shuangmidamo suppository and its preparing process |
| 01/10/2001 | CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof |
| 01/10/2001 | CN1060374C Ointment for treating hemorrhoid |
| 01/10/2001 | CN1060360C Oral liquor for treatment of cardiovascular disease |
| 01/10/2001 | CN1060355C Medicine for treating thoracal arthralgia by heart and stomach treatment at same time |
| 01/10/2001 | CN1060344C Medicinal preparation for curing ischemic angiocardiopathy or cerebrovascular disease |
| 01/10/2001 | CN1060332C Compound hypotensive hair-protective liquid and its preparing method |
| 01/09/2001 | US6172256 Chiral-β-amino acid compounds and derivatives thereof |
| 01/09/2001 | US6172250 Hydrolysis of an organosilicon compounds |
| 01/09/2001 | US6172237 Process for preparing eprosartan |
| 01/09/2001 | US6172086 Methods and compositions for stimulating neurite growth |
| 01/09/2001 | US6172072 Heterocyclically substituted benzamides and their use in fighting diseases |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172067 Analgesics, antiinflammatory agents |
| 01/09/2001 | US6172060 Therapy for sexual disorders |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171835 ribH |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/09/2001 | US6171609 Intravascular stent with cytoskeletal inhibitor; preventing stenosis or reducing restenosis |
| 01/09/2001 | US6171603 Treating skin, hair, cardiovascular, autoimmune and vision disorders; administering as anticarcinogenic, antidepressant,antiinflammatory, and antiacne agents |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/09/2001 | CA2117483C [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
| 01/04/2001 | WO2001000859A1 Method of inducing angiogenesis by micro-organs |
| 01/04/2001 | WO2001000821A1 Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000660A1 INHIBITORS OF THE INTEGRIN αvβ¿6? |
| 01/04/2001 | WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000653A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/04/2001 | WO2001000619A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 01/04/2001 | WO2001000618A1 Benzamide derivatives |
| 01/04/2001 | WO2001000613A1 Benzimidazole compounds and drugs containing the same |
| 01/04/2001 | WO2001000610A1 Substituted benzimidazole |
| 01/04/2001 | WO2001000603A1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/04/2001 | WO2001000588A1 Benzimidazole compounds and drugs containing the same |
| 01/04/2001 | WO2001000587A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 01/04/2001 | WO2001000579A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY |
| 01/04/2001 | WO2001000573A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
| 01/04/2001 | WO2001000229A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 01/04/2001 | WO2001000220A2 Lipoprotein lipase (lpl) variant therapeutics |
| 01/04/2001 | WO2001000211A1 A method for the treatment or prevention of coronary graft vasospasm |
| 01/04/2001 | WO2001000210A1 Reverse-turn mimetics and methods relating thereto |